movantik 12.5 MG Oral Tablet

RxCUI: 1551923
RxNorm name: movantik 12.5 MG Oral Tablet
Display name: movantik 12.5 MG Oral Tablet
Full name: movantik 12.5 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MOVANTIK	NALOXEGOL OXALATE	Valinor Pharma, LLC	28596788-b73f-4247-85fc-3105f51fff5a	2025-12-22	Warnings, Adverse reactions	Exact identifier rxcui: 1551923
MOVANTIK	NALOXEGOL OXALATE	RedHill Biopharma Ltd	300a6474-ebcd-4404-8040-48fdcfcc1635	2024-11-27	Warnings, Adverse reactions	Exact identifier rxcui: 1551923

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
300a6474-ebcd-4404-8040-48fdcfcc1635	movantik 12.5 MG Oral Tablet [PSN] · naloxegol 12.5 MG Oral Tablet [Movantik] [SBD] · Movantik 12.5 MG (as naloxegol oxalate 14.2 MG) Oral Tablet [SY] · Movantik 12.5 MG Oral Tablet [SY]	4	5	These highlights do not include all the information needed to use MOVANTIK safely and effectively. See full prescribing information for MOVANTIK. MOVANTIK ® (naloxegol) tablets, for oral use Initial U.S. Approval: 2014	20241127
28596788-b73f-4247-85fc-3105f51fff5a	movantik 12.5 MG Oral Tablet [PSN] · naloxegol 12.5 MG Oral Tablet [Movantik] [SBD] · Movantik 12.5 MG (as naloxegol oxalate 14.2 MG) Oral Tablet [SY] · Movantik 12.5 MG Oral Tablet [SY]	4	3	These highlights do not include all the information needed to use MOVANTIK safely and effectively. See full prescribing information for MOVANTIK. MOVANTIK ® (naloxegol) tablets, for oral use Initial U.S. Approval: 2014	20251222